About ClearPoint Neuro
ClearPoint Neuro is a company based in Irvine (United States) founded in 1998. It operates as a Direct-to-Consumer (D2C) and Professional Services. ClearPoint Neuro has raised $18.35 million across 8 funding rounds from investors including PTC Therapeutics, Oberland Capital and Petrichor. The company has 115 employees as of December 31, 2024. ClearPoint Neuro has completed 1 acquisition, including IRRAS. ClearPoint Neuro offers products and services including ClearPoint Navigation System, ClearPoint Prism Neuro Laser System, and SmartFlow Neuro Cannula. ClearPoint Neuro operates in a competitive market with competitors including Caresyntax, Augmedics, Proprio, IMRIS Deerfield Imaging and eCential Robotics, among others.
- Headquarter Irvine, United States
- Employees 115 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clearpoint Neuro Inc.
-
Annual Revenue
$31.39 M (USD)31.04as on Dec 31, 2024
-
Net Profit
-$18.91 M (USD)14.37as on Dec 31, 2024
-
EBITDA
-$17.84 M (USD)14.99as on Dec 31, 2024
-
Total Equity Funding
$18.35 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
PTC Therapeutics
& 2 more
-
Employee Count
115
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ClearPoint Neuro
ClearPoint Neuro is a publicly listed company on the NASDAQ with ticker symbol CLPT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ClearPoint Neuro
ClearPoint Neuro offers a comprehensive portfolio of products and services, including ClearPoint Navigation System, ClearPoint Prism Neuro Laser System, and SmartFlow Neuro Cannula.
Navigation system for precise brain and spine procedures.
Laser system used for targeted neurosurgical interventions.
Cannula designed for precise drug delivery in neurosurgery.
People of ClearPoint Neuro
Unlock access to complete
Unlock access to complete
Funding Insights of ClearPoint Neuro
ClearPoint Neuro has successfully raised a total of $18.35M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ClearPoint Neuro
ClearPoint Neuro has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include PTC Therapeutics, Oberland Capital and Petrichor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Locked | Locked | Locked | |
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Locked | Locked | Locked | |
|
Small molecule drugs for rare diseases are developed.
|
Locked | Locked | Locked |
Investor details for ClearPoint Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClearPoint Neuro
ClearPoint Neuro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include IRRAS.
Investment portfolio details for ClearPoint Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of devices for fluid control and management after surgery
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for ClearPoint Neuro
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ClearPoint Neuro
Detailed financials for ClearPoint Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clearpoint Neuro Comparisons
Peer comparison for ClearPoint Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ClearPoint Neuro
ClearPoint Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, Augmedics, Proprio, IMRIS Deerfield Imaging and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
Detailed competitors of ClearPoint Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clearpoint Neuro
Complete news archive for ClearPoint Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClearPoint Neuro
ClearPoint Neuro was founded in 1998 and raised its 1st funding round 13 years after it was founded.
ClearPoint Neuro is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Joe Burnett is the current CEO of ClearPoint Neuro.
ClearPoint Neuro is a funded company, having raised a total of $18.35M across 8 funding rounds to date.
As of Dec 31, 2024, the latest employee count at ClearPoint Neuro is 115.
Annual revenue of ClearPoint Neuro is $31.39M as on Dec 31, 2024.
ClearPoint Neuro is established as a global leader in device, cell, and gene therapy-enabling solutions. The company is focused on delivering precise navigation systems for brain and spine interventions. Comprehensive neurosurgical solutions are offered to healthcare professionals, emphasizing real-time imaging and intraprocedural adjustments. Support is provided for CNS drug delivery trials and translational research in gene and cell therapy. Collaboration with researchers on innovative projects is actively pursued, while patient comfort and targeted treatments are prioritized in neurosurgery advancements.
ClearPoint Neuro's top competitors include Caresyntax, Augmedics and Proprio.
ClearPoint Neuro offers ClearPoint Navigation System, ClearPoint Prism Neuro Laser System, and SmartFlow Neuro Cannula.
Yes, ClearPoint Neuro is publicly traded on NASDAQ under the ticker symbol CLPT.
ClearPoint Neuro has made 1 acquisition, including IRRAS.
ClearPoint Neuro has 3 investors. Key investors include PTC Therapeutics, Oberland Capital, and Petrichor.
The ticker symbol of ClearPoint Neuro is CLPT on NASDAQ.